Verition Fund Management
CRBU icon

Verition Fund Management’s Caribou Biosciences CRBU Stock Holding History

Verition Fund Management’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140,101
Closed -$223K – 3382
2024
Q4 		$223K Buy
+140,101
New +$282K ﹤0.01% 2933
2024
Q3 		– Sell
-19,562
Closed -$32.1K – 3241
2024
Q2 		$32.1K Buy
+19,562
New +$62.5K ﹤0.01% 2835
2022
Q3 		– Sell
-47,489
Closed -$258K – 3068
2022
Q2 		$258K Buy
+47,489
New +$363K 0.01% 1793

Other funds holding CRBU

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verition Fund Management's CRBU Position: Q1 2025 in Review

Verition Fund Management sold out of Caribou Biosciences (CRBU) in Q1 2025, closing a stake of 140,101 shares — an estimated $223K sold.

Verition Fund Management first reported a position in CRBU in Q2 2022 and held it in 3 quarters. The position peaked at $258K in Q2 2022. 131 funds tracked by Wall St. Rank hold CRBU as of Q1 2025.

  • Verition Fund Management reported no remaining Caribou Biosciences position as of Q1 2025 after selling out during the quarter.
  • Verition Fund Management sold 140,101 Caribou Biosciences shares in Q1 2025, an estimated $223K.
  • Verition Fund Management first reported a position in Caribou Biosciences in Q2 2022 and held it in 3 quarters.
  • Verition Fund Management's Caribou Biosciences position peaked at $258K in Q2 2022.
  • 131 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2025.

Based on Verition Fund Management's 13F filing for Q1 2025, filed 15 May 2025.